BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 33524869)

  • 1. Olaratumab (Lartruvo): An Innovative Treatment for Soft Tissue Sarcoma.
    Penniman L; Parmar S; Patel K
    P T; 2018 May; 43(5):267-270. PubMed ID: 29719366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.
    Yoon H; Tang CM; Banerjee S; Yebra M; Noh S; Burgoyne AM; Torre J; Siena M; Liu M; Klug LR; Choi YY; Hosseini M; Delgado AL; Wang Z; French RP; Lowy A; DeMatteo RP; Heinrich MC; Molinolo AA; Gutkind JS; Harismendy O; Sicklick JK
    Oncogene; 2021 Mar; 40(11):1957-1973. PubMed ID: 33603171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major impact of COVID-19 national containment on activities in the French northern comprehensive cancer center.
    Penel N; Hammoudi A; Marliot G; De Courreges A; Cucchi M; Mirabel X; Leblanc E; Lartigau E
    Med Oncol; 2021 Feb; 38(3):28. PubMed ID: 33595732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of rare late onset life-threatening pseudoprogression with immune check point inhibitors in advanced cancer patients - a case report.
    Coudert V; Robin YM; Tessier W; Forestier A; Penel N
    Acta Oncol; 2021 May; 60(5):683-686. PubMed ID: 33583310
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody-Drug Conjugate.
    Iida K; Abdelhamid Ahmed AH; Nagatsuma AK; Shibutani T; Yasuda S; Kitamura M; Hattori C; Abe M; Hasegawa J; Iguchi T; Karibe T; Nakada T; Inaki K; Kamei R; Abe Y; Nomura T; Andersen JL; Santagata S; Hemming ML; George S; Doi T; Ochiai A; Demetri GD; Agatsuma T
    Cancer Discov; 2021 Jun; 11(6):1508-1523. PubMed ID: 33579785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies.
    van de Stolpe A; Verhaegh W; Blay JY; Ma CX; Pauwels P; Pegram M; Prenen H; De Ruysscher D; Saba NF; Slovin SF; Willard-Gallo K; Husain H
    Front Genet; 2020; 11():598118. PubMed ID: 33613616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903).
    Friedlander M; Benson C; O'Connell RL; Reed N; Clamp A; Lord R; Millan D; Nottley S; Amant F; Steer C; Anand A; Mileshkin L; Beale P; Banerjee S; Bradshaw N; Kelly C; Carty K; Divers L; Alexander L; Edmondson R
    Gynecol Oncol; 2021 Apr; 161(1):160-165. PubMed ID: 33608144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report.
    Dipasquale A; Persico P; Lorenzi E; Rahal D; Santoro A; Simonelli M
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma.
    Wingerter A; El Malki K; Sandhoff R; Seidmann L; Wagner DC; Lehmann N; Vewinger N; Frauenknecht KBM; Sommer CJ; Traub F; Kindler T; Russo A; Otto H; Lollert A; Staatz G; Roth L; Paret C; Faber J
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33572900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma.
    Ke XY; Chen Y; Tham VY; Lin RY; Dakle P; Nacro K; Puhaindran ME; Houghton P; Pang A; Lee VK; Ding LW; Gery S; Hill J; Chen L; Xu L; Koeffler HP
    Oncogene; 2021 Mar; 40(10):1851-1867. PubMed ID: 33564073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial.
    Le Cesne A; Blay JY; Cupissol D; Italiano A; Delcambre C; Penel N; Isambert N; Chevreau C; Bompas E; Bertucci F; Chaigneau L; Piperno-Neumann S; Salas S; Rios M; Guillemet C; Bay JO; Ray-Coquard I; Haddag L; Bonastre J; Kapso R; Fraslin A; Bouvet N; Mir O; Foulon S
    Ann Oncol; 2021 Aug; 32(8):1034-1044. PubMed ID: 33932507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor biomarkers for diagnosis, prognosis and targeted therapy.
    Zhou Y; Tao L; Qiu J; Xu J; Yang X; Zhang Y; Tian X; Guan X; Cen X; Zhao Y
    Signal Transduct Target Ther; 2024 May; 9(1):132. PubMed ID: 38763973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis.
    Huang Y; Cao D; Zhang M; Yang Y; Niu G; Tang L; Shen Z; Zhang Z; Bai Y; Min D; He A
    Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38652223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer instincts: natural killer cells as multifactorial cancer immunotherapy.
    Nersesian S; Carter EB; Lee SN; Westhaver LP; Boudreau JE
    Front Immunol; 2023; 14():1269614. PubMed ID: 38090565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic signaling pathways and anti-angiogenic therapy for cancer.
    Liu ZL; Chen HH; Zheng LL; Sun LP; Shi L
    Signal Transduct Target Ther; 2023 May; 8(1):198. PubMed ID: 37169756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorafenib for the Treatment of Sarcoma.
    Blay JY; Duffaud F; George S; Maki RG; Penel N
    Curr Treat Options Oncol; 2022 Nov; 23(11):1477-1502. PubMed ID: 36178573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
    Brahmi M; Lesluyes T; Dufresne A; Toulmonde M; Italiano A; Mir O; Le Cesne A; Valentin T; Chevreau C; Bonvalot S; Penel N; Coindre JM; Le Guellec S; Le Loarer F; Karanian M; Blay JY; Chibon F
    ESMO Open; 2021 Feb; 6(1):100037. PubMed ID: 33524869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
    Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
    Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.